Conference Coverage
Conference Coverage
VIDEO: HER2+ patients may do fine with local therapies alone
MIAMI BEACH – Unquestionably, the advent of human epidermal growth factor receptor-2 (HER2) inhibitors has dramatically improved long-term...
Conference Coverage
VIDEO: Future therapies look promising for HER2 treatment-resistant breast cancer patients
Several antibody-drug conjugates and additional types of agents are showing promise for HER2 treatment-resistant breast cancer.
Conference Coverage
VIDEO: Breast surgeons can and do provide genetic counseling to cancer patients
MIAMI BEACH – Breast surgeons are qualified to help counsel patients and already order more than half of breast cancer genetic sequencing.
Conference Coverage
VIDEO: Resistance to endocrine therapy a moving target
MIAMI BEACH – Dr. William J. Gradishar discusses strategies for combating resistance to endocrine ablative therapy in a video interview.
Conference Coverage
Miami Breast Cancer Symposium to explore treatment controversies
Sessions will explore treatment controversies, such as omitting anthracyclines, extended-field radiation therapy, and who should be receiving...
Conference Coverage
START again shows safety of hypofractionated doses in early breast cancer
AMSTERDAM – Analyses of patient-reported outcomes in the UK START A and B trials show that radiation doses greater than 2 Gy to the...
Conference Coverage
Survival better with breast-conserving therapy for early cancers
AMSTERDAM – Breast cancer–specific survival and overall survival were better among women who had breast-conserving therapy (BCT) compared with...
Conference Coverage
Axial radiotherapy noninferior to cALND in early invasive breast cancer
Women with early breast cancer with only sentinel lymph node involvement may be able to be spared morbidity from axillary dissection.
Conference Coverage
Circulating microRNAs may predict breast cancer treatment response
SAN ANTONIO – Circulating microRNAs may predict treatment response in HER2-positive breast cancer patients treated with neoadjuvant therapy,...
Conference Coverage
CTCs help predict breast cancer outcomes in neoadjuvant setting
SAN ANTONIO – Circulating tumor cells are a useful prognostic biomarker in early breast cancer patients treated with neoadjuvant chemotherapy,...